Data from Pharmawand - Curated by Marshall Pearce - Date added 11 September 2017

Eisai announced a delay in the deterioration of five health-related quality of life domains that affect patients' daily lives was observed in patients treated with Lenvima (lenvatinib) as compared to those treated with sorafenib in the Phase III REFLECT study evaluating lenvatinib compared to sorafenib in patients with unresectable hepatocellular carcinoma (HCC). Quality of life scores declined with both treatments over the course of the study.

The secondary endpoint of HRQOL was assessed using the EORTC QLQ-C30 questionnaire and the HCC-specific module (EORTC QLQ-HCC18). Treatment with lenvatinib resulted in a longer median time to delay in worsening in the QLQ-C30 domains of role function (2.0 months vs 1.9 months; nominal p=0.0098), pain (2.0 months vs 1.8 months; nominal p=0.006) and diarrhea (4.6 months vs 2.7 months; nominal p<0.0001), and in the QLQ-HCC18 domains of body image (2.8 months vs 1.9 months; nominal p=0.0041) and nutrition (4.1 months vs 2.8 months; nominal p=0.006). There were no nominally significant differences in the other domains of the two scales (QLQ-C30 and QLQ-HCC18). Baseline HRQOL scores were similar for patients receiving either treatment across all domains. These data were presented at the European Society of Medical Oncology (ESMO) 2017 Congress.


You will need to login, to leave a comment. is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Breakthrough Cancer Pain Learning Zone

Breakthrough Cancer Pain Learning Zone

Watch video highlights from the BeCOn OWN 2017 event, including expert opinion, patient experience and panel discussions in the Breakthrough Cancer Pain Learning Zone.

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Load more

Related Content